PSTO 11: P1110, A Phase I Trial to Evaluate the Safety and Pharmacokinetics of Raltegravir in HIV-1 Exposed Neonates at High Risk of Acquiring HIV-1 Infection

Project: Research project

Project Details

StatusFinished
Effective start/end date1/1/1512/31/15

Funding

  • Johns Hopkins University
  • Merck Sharp & Dohme Corp